Results 41 to 50 of about 534,042 (160)
Involvement of membrane CD83 / soluble CD83 in autoimmune pemphigus
Le pemphigus est un groupe hétérogène de maladies bulleuses auto-immunes intra-épithéliales où les lymphocytes B produisent des auto-anticorps pathogènes directement responsables des lésions bulleuses et érosives, cutanées et muqueuses.
Bohelay, Gérôme
core
Targeting CD83 for the treatment of graft-versus-host disease
Graft-versus-host disease (GVHD) is a common and often fatal complication of bone marrow transplantation. Antigen-presenting cells from donor and recipient play a critical role in the initiation and maintenance of GVHD.
Wang, Xiongfei +5 more
core +1 more source
Measurement of cytokines (IL-10, IL-12 p70, IFN-gamma, TGF-beta), soluble CD83 and Prostaglandin E2 (PGE2)
Johan Carlsson (826313)
core +1 more source
Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation [PDF]
Chronic inflammatory diseases and transplant rejection represent major challenges for modern health care. Thus, identification of immune checkpoints that contribute to resolution of inflammation is key to developing novel therapeutic agents for those ...
Dmytro Royzman +17 more
core +1 more source
Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes [PDF]
The transmembrane protein CD83, expressed on APCs, B cells, and T cells, can be expressed as a soluble form generated by alternative splice variants and/or by shedding.
Nicolette CA +8 more
core +3 more sources
NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis
Natural killer (NK) cells represent a subset of lymphocytes that contribute to innate immunity and have been reported to play a role in autoimmune uveitis. However, the mechanisms regulating NK cellular function in this condition remain unclear.
Wei Lin +8 more
doaj +1 more source
Inflammatory and Immunological Basis of Periodontal Diseases
The periodontal lesion emerges as an evolving immunological battlefield, where host–microbiome interactions, dysregulated immune responses, fragile resolution mechanisms, and inflammophilic dysbiosis converge to shift the balance from homeostasis to unrestrained tissue destruction.
Giacomo Baima +3 more
wiley +1 more source
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi +6 more
wiley +1 more source
Background Dendritic cells (DCs) are antigen presenting cells capable of inducing innate and adaptive immune responses. According to the stimulus and their maturation state, DCs induce immunogenic or tolerogenic responses.
Delézay Olivier +7 more
doaj +1 more source
Oncolytic Virus‐Engineered Extracellular Vesicles Rewire Glioblastoma Immunity
ABSTRACT Immunotherapy with oncolytic Herpes simplex virus type 1 (oHSV‐1) shows promise for glioblastoma; however, clinical benefit remains uncommon due to tumour‐ and host‐mediated immunosuppression, which limits immune targeting of residual glioblastoma stem‐like cells (GSCs). To address this barrier, extracellular vesicles (EVs) harvested from oHSV‐
Klaudia Kiel +18 more
wiley +1 more source

